Surgical Robots Market Share

North America Market Insights 

North America is expected to dominate the global surgical robots’ market with a share of 47% by the end of 2037. Strong contributors include rising demand for minimally invasive procedures, government funding, and payer system endorsement. The U.S. has a well-established reimbursement structure that supports an infrastructure for wider adoption, standard DRGs, and CPT codes for robotic procedures. Canada's provincial healthcare systems have pushed to incorporate robots into public hospitals. Furthermore, growth is driven by rising surgical volumes from aging patient populations and incidences of chronic disease, and trending to a preferred methodology of precision techniques. In Canada, a regulatory support environment and regional utilization growth are encouraging growth across regions. Public sector funding for hospital infrastructure through provincial budgets for robotics expansion has translated into deployment at over 200 centers.

Federal budget structures support surgical robotic development. HHS and NIH provide grants for research and technology, although CMS reimbursement provided through Medicare improves access to coverage. Medicare does not charge an additional payment for robotic assistance under the DRG methodology. CDC and AHRQ constitute another budget line that also finances surgical robotic development indirectly through workforce development. FDA approval pathways are still in place and expanding. Major trends include expansion of Medicare-approved robotic procedures and reimbursement for robotic procedures by private insurers predicted that the U.S. surgical robotics market is expected to grow.

APAC Market Insights 

Asia Pacific is poised to register the highest pace of growth in the global surgical robots market by the end of 2037. The growth is driven by rising healthcare investments, aging populations, and preference for minimally invasive surgeries. Japan and China will dominate the regional market. Japan's allocations show that the national healthcare plan allocates 13% to surgical robotics in 2024. Japan's minimum health budget increased from two years ago was USD 2 billion. China's allocation in recent years has shown a 14% growth in spending on robotic surgery systems by the National Medical Products Administration (NMPA). This allowed surgical robots to perform more than 1.2 million surgical procedures in 2023.

In India, government spending increased 17% from 2015 to 2023. Malaysia also saw patient numbers double from 2013 to 2023. South Korea has continued to develop its robotic surgery industry while still subsidizing robotic surgery. Market expansion is also credited in this region to several partnerships between multinational robotic system manufacturers and local hospitals. By 2037, Japan and China will be estimated to combine for over 54% of regional market revenue.

Europe Market Insights 

The Europe surgical robots market is estimated to garner a notable industry value from 2025 to 2037. The growth can be attributed to the high healthcare spending and supportive regulation. The UK market is estimated to be £1.1 billion in 2024. An increase in funding is indicative of a surge in demand for the da Vinci Robot, with 43% of all prostatectomies now carried out as robotic-assisted. The ABPI has predicted that 11% annual growth in robotic surgery will be driven by AI uptake. Germany is the top country in Europe for spending on surgical robots. In France, the agencies reporting has stated that 6% of the healthcare budget was available for surgical robots in 2023. The emerging "My Health 2025" plan implicitly prioritizes robotic surgery.

Government Investment & Development in Surgical Robots Market